Description
Regulatory description in preparation. This entry is part of the enriched CosIng dataset published by BD-API and will be completed with the corresponding editorial review.
Last CosIng update
27 November 2022
Regulatory description in preparation. This entry is part of the enriched CosIng dataset published by BD-API and will be completed with the corresponding editorial review.
Maximum permitted concentration
10 % (In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %).
Regulatory framework
Regulation (EC) No 1223/2009 — Annex VI, ref. 34
Last update reflected in the database: 27 November 2022
Conditions of use
Only nanomaterials having the following characteristics are allowed: — Purity ≥ 97 % —Median particle size D50 (50 % of the number below this diameter): ≥ 50 nm of number size distribution. Not to be used in applications that may lead to exposure of the end user’s lungs by inhalation.
No analyses published yet for this substance. This section will be filled with regulatory blog articles as they are published.
Data source: Official CosIng from the European Commission, updated on 27 November 2022. Learn more →